Publicaciones (33) Publicaciones de Juan José Gil Fernández

2020

  1. Jumping Translocation in a Patient with Acute Leukemia and Fatal Evolution

    Case Reports in Oncology, Vol. 13, Núm. 2, pp. 1026-1030

2018

  1. Association between breast MALT lymphoma and hepatitis C virus: Report of two cases and literature review

    Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 273-277

2016

  1. A team-based multidisciplinary approach to managing peripherally inserted central catheter complications in high-risk haematological patients: a prospective study

    Supportive Care in Cancer, Vol. 24, Núm. 1, pp. 93-101

  2. Epidemiología de la leucemia mieloide crónica en España y sus posibles implicaciones terapéuticas

    Revista Clinica Espanola

2015

  1. Atypical IgM multiple myeloma with deletion of c-MAF

    International Journal of Laboratory Hematology, Vol. 37, Núm. 5, pp. 686-689

2013

  1. Inmunoglobulinas intravenosas en los episodios graves de anemia hemolítica autoinmune: resultados comparativos en 21 episodios de un único centro

    Medicina Clinica, Vol. 141, Núm. 5, pp. 201-204

  2. Two-weekly dose-adjusted (DA)-EPOCH-like chemotherapy with high-dose dexamethasone plus rituximab (DA-EDOCH14-R) in poor-prognostic untreated diffuse large B-cell lymphoma

    British Journal of Haematology, Vol. 160, Núm. 4, pp. 510-514

2011

  1. Sepsis fulminante y rabdomiólisis por Bacillus cereus en paciente con enfermedad de Hodgkin

    Enfermedades Infecciosas y Microbiologia Clinica

2010

  1. Clonal evolution in patients with chronic lymphocytic leukemia

    Leukemia and Lymphoma

2008

  1. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: A significant number result from unrecognized co-administration of several drugs

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 12, pp. 3762-3766

2006

  1. Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome

    Leukemia Research, Vol. 30, Núm. 8, pp. 957-963

2005

  1. Non-Hodgkin's lymphoma and urinary tract. About a case reported

    Actas Urologicas Espanolas, Vol. 29, Núm. 4, pp. 427-432

2004

  1. Mixedema grave como causa de transformación gelatinosa de la médula ósea reversible tras tratamiento tiroideo sustitutivo

    Medicina Clinica

2003

  1. Portal hypertension in Williams syndrome: Report of two patients

    American Journal of Medical Genetics, Vol. 118 A, Núm. 4, pp. 372-376

  2. Quality of life and psychological well-being in Spanish long-term survivors of Hodgkin's disease: Results of a controlled pilot study

    Annals of Hematology, Vol. 82, Núm. 1, pp. 14-18

2002

  1. ATRA-induced myositis in induction therapy of acute promyelocytic leukemia.

    Haematologica, Vol. 87, Núm. 2

  2. Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.

    Haematologica, Vol. 87, Núm. 1

  3. Ca-125 as a tumor marker in a patient with non-Hodgkin's lymphoma [2]

    Medicina Clinica

  4. Deletion of sequences flanking the t(9;22) breakpoint: A secondary genetic event associated with loss of cytogenetic response to interferon in a Philadelphia-positive chronic myeloid leukaemia patient

    British Journal of Haematology, Vol. 117, Núm. 3, pp. 617-619

2001

  1. A giant hepatic mass of myeloid metaplasia in a patient without myelofibrosis

    Haematologica, Vol. 86, Núm. 4, pp. 445